Skip to main content
Clinical Trials/NCT00581503
NCT00581503
Withdrawn
Not Applicable

Optical Coherence Tomography for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

University of California, Irvine2 sites in 1 countryMarch 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
University of California, Irvine
Locations
2
Primary Endpoint
Pathology results.
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

This study has been designed to utilize already obtained biopsy specimens for investigation of the utility of a new, non-invasive optical diagnostic technique. The study will allow a careful correlation between the Optical coherence tomography findings and conventional histology.

Detailed Description

Optical coherence tomography is a non-invasive diagnostic technique that can provide information about tissue abnormalities, change in structure of an organ. This technique uses a near-infrared diode to emit light that can produce images of the specimen under investigation without causing damage or alterations.

Registry
clinicaltrials.gov
Start Date
March 2007
End Date
July 2018
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Beckman Laser Institute and Medical Center

Matthew Brenner, M.D.,Department of Pulmonary and Critical Care Medicine

University of California, Irvine

Eligibility Criteria

Inclusion Criteria

  • Adult 18 years and older
  • Having procedure of endobronchial, transbronchial, and / or pleural biopsy

Exclusion Criteria

  • Currently participating in any other investigational drug or device evaluation.
  • Currently taking drugs that are sensitive to light.

Outcomes

Primary Outcomes

Pathology results.

Time Frame: 30 minutes

Study Sites (2)

Loading locations...

Similar Trials